|

Effects of idebenone
on neurological deficits, local cerebral blood flow, and energy metabolism in
rats with experimental cerebral ischemia.
Nagaoka A, Suno M, Shibota M, Kakihana M.
Central Research Division,
Takeda Chemical Industries, Ltd., Osaka, Japan.
Arch Gerontol Geriatr 1989 May;8(3):193-202
ABSTRACT
Improvement of energy metabolism in
ischemic cerebral tissue benefits the therapy of occlusive cerebrovascular
disorders. In the present study, the effects of (idebenone on
neurological signs, such as ischemic seizures, lactate and ATP contents of the
cerebral cortex, and local cerebral blood flow, were assessed in stroke-prone
spontaneously hypertensive rats (SHRSP) with experimentally induced cerebral
ischemia. Experimental cerebral ischemia was caused by bilateral carotid
artery occlusion (BCAO) in male SHRSP (8-10 weeks old). Pretreatment with
idebenone (10-100 mg/kg, p.o.) for 3 or 10 days delayed the onset of ischemic
seizure (acute stroke) and prolonged survival time in SHRSP roughly in a
dose-dependent manner. When the compound (100 mg/kg, i.p.) was given once 30
min after BCAO, it exerted similar ameliorating effects on the neurological
deficits. When idebenone (100 mg/kg for 3 days) was given orally, it did not
significantly inhibit the decrease in regional cerebral blood flow induced by
BCAO. However, the same treatment markedly inhibited increases in the lactate
content and lactate/pyruvate ratio and the decrease in ATP content of the
cerebral cortex. The compound did not affect cerebral blood flow in normal
rats. These results suggest that idebenone ameliorates the neurological
deficits related to cerebral ischemia, and that this effect is mediated by
improving cerebral energy metabolism.
Idebenone
- the ultimate anti-aging drug. (article)
Alzheimer's disease
Idebenone in
the treatment of Alzheimer's disease
Idebenone
efficacy of idebenone in the treatment of Alzheimer's
disease
Idebenone
Nerve Growth Factor synthesis stimulators in Alzheimer's
disease
Idebenone
in the treatment of dementia of the Alzheimer
type
Idebenone
cognitive enhancement therapy for Alzheimer's
disease
Friedreich's ataxia.
Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.
Idebenone
causes improvement in mitochondrial
cardiomyopathy
Idebenone
cerebellar improvement in Friedreich's ataxia after 3 months
Idebenone effect
of idebenone on cardiomyopathy in Friedreich's ataxia
Idebenone
Friedreich's ataxia and frataxin
Idebenone Frataxin: Its
role in iron metabolism and Friedreich's Ataxia
Idebenone mitochondrial dysfunction in Friedreich's ataxia
Idebenone helps
heart function
in Friedreich's ataxia
MELAS
Idebenone
improves cerebral mitochondrial oxidative metabolism in MELAS
Idebenone
in young patients with mitochondrial encephalomyopathy (MELAS)
Idebenone
therapy in Mitochondrial encephalomyopathy (MELAS)
Idebenone
and Mitochondrial encephalomyopathy (MELAS)
Idebenone
successful therapy with idebenone in Mitochondrial
encephalomyopathy (MELAS)
.
Cardiomyopathy
Idebenone
improvement in mitochondrial cardiomyopathy
following treatment with idebenone
Idebenone
effect of idebenone on
cardiomyopathy in Friedreich's ataxia
.
Leber hereditary optic neuropathy (LHON)
Idebenone
does it shorten the time to visual recovery in Leber hereditary optic
neuropathy?
Idebenone
improvement in a patient with Leber's hereditary optic neuropathy (LHON)
Misc.
Idebenone
use in age-related cognitive disorders
Idebenone
protects hippocampal neurons against beta amyloid neurotoxicity
Idebenone
functions as a potent protective
hepatocyte antioxidant
Idebenone
neuroprotective effects
of idebenone can be attributed to its antioxidant ability
Idebenone
inhibition of brain
mitochondrial swelling
Idebenone
suppression of cold ischemia/reperfusion
injury of liver endothelium
Idebenone
ability to eliminate a nitroxide
radical in the rat
Idebenone
interaction with respiratory complexes of heart
mitochondria
Idebenone
effect on serotonin release and seroton receptors in
rats
Idebenone
protects hepatic microsomes against damage in organ preservation solutions
Idebenone
protects against
toxicity induced by low density lipoprotein
Idebenone
protects against disorders due to cerebral hypoxia
or ischemia
Idebenone
protects against toxicity induced by low density
lipoprotein
Idebenone
attenuates neuronal degeneration induced by
excitotoxins
Idebenone
augments long-term potentiation in
hippocampal slices in the guinea pig
Idebenoneeffects
on lipid
peroxidation in erythrocytes of stroke-prone, hypertensive rats
Idebenone
brain distribution and its effect on local cerebral
glucose utilization in rats
Idebenone
effects
on acetylcholine
levels in the brains of rats with cerebral ischemia
Idebenone
protective effect of idebenone against hypoxia in
mice
Idebenone
improves learning and memory impairment induced in
rats
Idebenone
effects
of idebenone on
neurological deficits in stroke-prone rats
Idebenone
effects
on memory induced impairment in rats
Idebenone
effects of idebenone on cerebral blood flow in rats with cerebral ischemia
Idebenone
inhibition
of brain mitochondrial swelling by idebenone
Idebenone
inhibition of platelet
aggregation by idebenone
Idebenone
effects of idebenone on monoamine metabolites of
patients with dementia
Idebenone
effects of idebenone on
metabolism of monoamines and cyclic AMP formation
Idebenone effects
on impairment of radial maze learning in cerebral embolized rats
Idebenone
effect of idebenone on lipid peroxidation in
rat brain homogenate
Idebenone
effects on muricidal behavior in rats with
raphe lesions
Idebenone
inhibitory effect of idebenone on vascular lesions in
hypertensive rats
Vinpocetine | Galantamine | CDP Choline |
Picamilon
Pyritinol | Modafinil | Deprenyl | Piracetam
Home | Order
|